Familial haemophagocytic lymphohistiocytosis treated with allogeneic bone marrow transplantation
Nespoli, L.; Locatelli, F.; Bonetti, F.; Porta, F.; Zecca, M.; Gibardi, A.; Gambarana, D.; Vitale, V.; Burgio, G.R.; Severi, F.
Bone Marrow Transplantation 7(Suppl 3): 139-142
1991
ISSN/ISBN: 0268-3369 PMID: 1855079 Document Number: 368214
Document emailed within 1 workday
Related Documents
Spísek, R.; Mejstríková, E.; Formánková, R.; Zizková, H.; Vávra, V.; Hrusák, O.; Sedivá, A.; Sedlácek, P.; Starý, J. 2006: Familial haemophagocytic lymphohistiocytosis caused by perforin deficit can be successfully treated by haematopoietic stem cell transplantation--the first diagnosed case in the Czech Republic Casopis Lekaru Ceskych 145(1): 50-54Ahmed, T.; Mehta, R.; Patel, P.; Kaul, R.; Kaul, A. 1989: Bone marrow transplantation for familial hemophagocytic lymphohistiocytosis Anticancer Research 9(6): 1567-1568
De Witte, T.; Schattenberg, A.; Preijers, F.; Raymakers, R.; Muus, P.; Wessels, J. 1993: Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation Bone Marrow Transplantation 12(Suppl 3): S2-S6
Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475
Harada, M.; Gondo, H.; Taniguchi, S. 1990: Conditioning regimens for diseases treated by allogeneic bone marrow transplantation Nihon Rinsho. Japanese Journal of Clinical Medicine 48(9): 2013-2022
Locasciulli, A.; Nava, S.; Sparano, P.; Testa, M. 1998: Infections with hepatotropic viruses in children treated with allogeneic bone marrow transplantation Bone Marrow Transplantation 21(Suppl 2): S75-S77
Michallet, M.; Corront, B.; Hollard, D.; Gratwohl, A.; Domingo, A.; Burnett, S. 1988: Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: report from the European Cooperative Group for bone marrow transplantation (8 cases) Nouvelle Revue Francaise d'Hematologie 30(5-6): 467-470
Locasciulli, A.; Alberti, A.; de Bock, R.; Cordonnier, C.; Einsele, H.; Engelhard, D.; Grundy, J.; Reusser, P.; Ribaud, P.; Ljungman, P. 1994: Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party Bone Marrow Transplantation 14(5): 833-837
Kodera, Y.; Yamada, H.; Morishima, Y.; Ohno, R.; Yoshikawa, S.; Yamada, K. 1986: Influence of pretransplant clinical conditions on the prognosis of patients treated with allogeneic bone marrow transplantation during leukemia relapse Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 49(1): 86-92
De Witte, T.; Zwaan, F.; Hermans, J.; Vernant, J.; Kolb, H.; Vossen, J.; Lönnqvist, B.; Beelen, D.; Ferrant, A.; Gmür, J. 1989: Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes. Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG) Bone Marrow Transplantation 4(Suppl 3): 38-39
Marmont, A.M. 1979: Transplantation haemopoiesis. Morphological bone marrow studies after allogeneic marrow transplantation in man for severe aplastic anaemia and acute leukaemia Nouvelle Revue Francaise d'Hematologie 21(2): 133-148
Martin-Algarra, S.; Bishop, M.R.; Tarantolo, S.; Cowles, M.K.; Reed, E.; Anderson, J.R.; Vose, J.M.; Bierman, P.; Armitage, J.O.; Kessinger, A. 1995: Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis Experimental Hematology 23(14): 1503-1508
Merino, A.; Urbano-Ispizua, A.; Marín, P.; Besson, I.; Carreras, E.; Sierra, J.; Salgado, C.; Rovira, M.; Grañena, A.; Montserrat, E. 1993: Immunophenotyping study of bone marrow fractions obtained by elutriation in allogeneic bone marrow transplantation Sangre 38(5): 359-364
del Rosario Uriarte, M.; Bonomi, R.; Azambuja, C.; Seuánez, H.N. 1997: Bone marrow reconstitution with normal autologous cells demonstrated by VNTR analysis after allogeneic bone marrow transplantation for chronic myelogenous leukemia Leukemia 11(12): 2213-2214
Davies, S.M.; Weisdorf, D.J.; Haake, R.J.; Kersey, J.H.; McGlave, P.B.; Ramsay, N.K.; Blazar, B.R. 1994: Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation Bone Marrow Transplantation 14(1): 73-77
Hassan, H.T.; Krog, C.; Stockschläder, M.; Schleimer, B.; Zeller, W.; Krüger, W.; Erttmann, R.; Zander, A.R. 1997: Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience Anticancer Research 17(1b): 589-599
Fay, J.W.; Collins, R.H.; Piñeiro, L. 1993: Allogeneic bone marrow transplantation using unrelated marrow donors Bone Marrow Transplantation 11(Suppl 1): 81-82
Fegan, C.; Thomas, H.; Bailey-Wood, R.; Coleman, S.; Phillips, S.; Hoy, T.; Whittaker, J.A. 1995: In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation Bone Marrow Transplantation 16(2): 277-281
Rozman, C.; Grañena, A.; Marín, P.; Hernández-Prieto, M.; Nomdedeu, B.; Montserrat, E.; Feliu, E.; Bladé, J.; Cervantes, F.; Vives Corrons, J.L. 1985: Allogeneic marrow transplantation in severe bone marrow aplasia. Factors determining the outcome in a series of 27 consecutive cases Medicina Clinica 84(4): 129-134
Stockschläder, M.; Krüger, W.; Kroschke, G.; Zeller, W.; Hoffknecht, M.; Löliger, C.; Kabisch, H.; Zander, A. 1995: Use of cryopreserved bone marrow in allogeneic bone marrow transplantation Bone Marrow Transplantation 15(4): 569-572